IBDEI165 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19876,2)
 ;;=^5015649
 ;;^UTILITY(U,$J,358.3,19877,0)
 ;;=N31.9^^84^925^70
 ;;^UTILITY(U,$J,358.3,19877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19877,1,3,0)
 ;;=3^Neurogenic Bladder Dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,19877,1,4,0)
 ;;=4^N31.9
 ;;^UTILITY(U,$J,358.3,19877,2)
 ;;=^5015648
 ;;^UTILITY(U,$J,358.3,19878,0)
 ;;=N31.1^^84^925^71
 ;;^UTILITY(U,$J,358.3,19878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19878,1,3,0)
 ;;=3^Neuropathic Bladder,Reflex NEC
 ;;^UTILITY(U,$J,358.3,19878,1,4,0)
 ;;=4^N31.1
 ;;^UTILITY(U,$J,358.3,19878,2)
 ;;=^5015645
 ;;^UTILITY(U,$J,358.3,19879,0)
 ;;=N32.89^^84^925^5
 ;;^UTILITY(U,$J,358.3,19879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19879,1,3,0)
 ;;=3^Bladder Disorders,Other Spec
 ;;^UTILITY(U,$J,358.3,19879,1,4,0)
 ;;=4^N32.89
 ;;^UTILITY(U,$J,358.3,19879,2)
 ;;=^87989
 ;;^UTILITY(U,$J,358.3,19880,0)
 ;;=N33.^^84^925^4
 ;;^UTILITY(U,$J,358.3,19880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19880,1,3,0)
 ;;=3^Bladder Disorders,Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,19880,1,4,0)
 ;;=4^N33.
 ;;^UTILITY(U,$J,358.3,19880,2)
 ;;=^5015654
 ;;^UTILITY(U,$J,358.3,19881,0)
 ;;=N34.2^^84^925^99
 ;;^UTILITY(U,$J,358.3,19881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19881,1,3,0)
 ;;=3^Urethritis
 ;;^UTILITY(U,$J,358.3,19881,1,4,0)
 ;;=4^N34.2
 ;;^UTILITY(U,$J,358.3,19881,2)
 ;;=^88231
 ;;^UTILITY(U,$J,358.3,19882,0)
 ;;=N34.1^^84^925^100
 ;;^UTILITY(U,$J,358.3,19882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19882,1,3,0)
 ;;=3^Urethritis,Nonspec
 ;;^UTILITY(U,$J,358.3,19882,1,4,0)
 ;;=4^N34.1
 ;;^UTILITY(U,$J,358.3,19882,2)
 ;;=^5015655
 ;;^UTILITY(U,$J,358.3,19883,0)
 ;;=N39.0^^84^925^104
 ;;^UTILITY(U,$J,358.3,19883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19883,1,3,0)
 ;;=3^Urinary Tract Infection,Site Not Spec
 ;;^UTILITY(U,$J,358.3,19883,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,19883,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,19884,0)
 ;;=N31.0^^84^925^72
 ;;^UTILITY(U,$J,358.3,19884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19884,1,3,0)
 ;;=3^Neuropathic Bladder,Uninhibited NEC
 ;;^UTILITY(U,$J,358.3,19884,1,4,0)
 ;;=4^N31.0
 ;;^UTILITY(U,$J,358.3,19884,2)
 ;;=^5015644
 ;;^UTILITY(U,$J,358.3,19885,0)
 ;;=R31.9^^84^925^54
 ;;^UTILITY(U,$J,358.3,19885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19885,1,3,0)
 ;;=3^Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,19885,1,4,0)
 ;;=4^R31.9
 ;;^UTILITY(U,$J,358.3,19885,2)
 ;;=^5019328
 ;;^UTILITY(U,$J,358.3,19886,0)
 ;;=R31.0^^84^925^52
 ;;^UTILITY(U,$J,358.3,19886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19886,1,3,0)
 ;;=3^Hematuria,Gross
 ;;^UTILITY(U,$J,358.3,19886,1,4,0)
 ;;=4^R31.0
 ;;^UTILITY(U,$J,358.3,19886,2)
 ;;=^5019325
 ;;^UTILITY(U,$J,358.3,19887,0)
 ;;=R31.2^^84^925^53
 ;;^UTILITY(U,$J,358.3,19887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19887,1,3,0)
 ;;=3^Hematuria,Microscopic
 ;;^UTILITY(U,$J,358.3,19887,1,4,0)
 ;;=4^R31.2
 ;;^UTILITY(U,$J,358.3,19887,2)
 ;;=^5019327
 ;;^UTILITY(U,$J,358.3,19888,0)
 ;;=R31.1^^84^925^51
 ;;^UTILITY(U,$J,358.3,19888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19888,1,3,0)
 ;;=3^Hematuria,Benign Essential Microscopic
 ;;^UTILITY(U,$J,358.3,19888,1,4,0)
 ;;=4^R31.1
 ;;^UTILITY(U,$J,358.3,19888,2)
 ;;=^5019326
 ;;^UTILITY(U,$J,358.3,19889,0)
 ;;=N40.0^^84^925^30
 ;;^UTILITY(U,$J,358.3,19889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19889,1,3,0)
 ;;=3^Enlarged Prostate w/o Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,19889,1,4,0)
 ;;=4^N40.0
 ;;^UTILITY(U,$J,358.3,19889,2)
 ;;=^5015689
 ;;^UTILITY(U,$J,358.3,19890,0)
 ;;=N40.1^^84^925^29
